Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
75 Cards in this Set
- Front
- Back
Amitriptyline, Imipramine, Desipramine
|
TCA
|
|
Nortriptyline, Protriptyline, Trimipramine
|
TCA
|
|
Doxepin
|
TCA
|
|
TCA approved for OCD, but 250 max dose d/t > risk of seizures
|
Clompiramine (Anafranil)
|
|
BN of Clompiramine
|
Anafranil, TCA
|
|
TCA with therapeutic window (50-150 ng/mL)
|
Nortriptyline
|
|
Antidepressants with slow cardiac conductions and lower seizure threshold
|
TCAs
|
|
TCA SE
|
Anticholinergic, sedation, ortho hypO, sexual
|
|
BN of Citalopram
|
Celexa, SSRI
|
|
BN of Escitalopram
|
Lexapro, SSRI
|
|
BN of Fluozetine
|
Prozac, SSRI
|
|
BN of Fluvoxamine
|
Luvox, SSRI
|
|
BN of Paroxetine
|
Paxil, SSRI
|
|
BN of Sertraline
|
Zoloft, SSRI
|
|
SE of SSRIs
|
Sexual and GI
|
|
Difference in SE of SSRIs from TCAs
|
SSRIs NO anticholinergic, sedation, or ortho hypO
|
|
SSRI approved for the tx of GAD
|
Escitalopram (Lexapro)
|
|
SSRI indicated for OCD
|
Fluvoxamine (Luvox)
|
|
SSRI Approved for the tx of premenstrual dysphoric disorder
|
Paroxetine (Paxil)
|
|
SSRI that is important to taper
|
Paroxetine (Paxil)
|
|
Hyponatremia has occurred in older patients receiving this class of drugs
|
SSRIs
|
|
SSRI with very high GI SE
|
Sertraline (Zoloft)
|
|
Phenelzine, Tranylcypromine
|
MAOIs (avoid tyramine foods and sympathomimetic agents to < risk of HTN crisis)
|
|
Amoxapine
|
TCA
|
|
BN of Bupropion
|
Wellbutrin (NDRI)
|
|
BN of Duloxetine
|
Cymbalta, SNRI
|
|
Duloxetine, (Cymbalta)
|
SNRI
|
|
BN of Mirtazipine
|
Remeron, alpha 1 antagonist
|
|
Mirtazapine, (Remeron)
|
alpha 2 antagonist
|
|
BN of Trazodone
|
Desyrel, (S2RI)
|
|
BN of Venlafaxine
|
Effexor (SNRI)
|
|
Venlafaxine (Effexor)
|
SNRI
|
|
Two very high SE with Trazodone
|
Ortho hypO and sedation
|
|
TCA that may cause tardive dyskinesia
|
Amoxapine
|
|
Avoid in pts with seizure disorders
|
Bupropion (Wellbutirin), NDRI
|
|
SNRI also approved for tx of diabetic neuropathic pain
|
Duloxetine (Cymbalta), SNRI
|
|
alpha 2 antagonist with high weight gain
|
Mirtazipine (Remeron)
|
|
SNRI approved for GAD and social anxiety disorder
|
Venlafaxine (Effexor)
|
|
BN of Carbamazepine
|
Tegretol, MS
|
|
BN of Gabapentin
|
Neurontin, MS
|
|
BN of Lamotrigine
|
Lamictal, MS
|
|
BN of Valproic Acid
|
Depakote, MS
|
|
High potential for SJS
|
Lamotrigine, Lamictal
|
|
SE of Valproic Acid
|
Hepatoxicity and parncreatitis
|
|
BN of Diphenydramine
|
Benadryl
|
|
BN of Doxylamine
|
Unisom, Antihistamine
|
|
BN of Zolpidem
|
Ambien, omega 1 receptor agonist
|
|
BN of Alprazolam
|
Xanax
|
|
BN of Clonazepam
|
Klonopin
|
|
BN of Diazepam
|
Valium
|
|
BN of Lorazepam
|
Ativan
|
|
BN of Buspirone
|
BuSpar (Anxiolytic)
|
|
BN of Hydroxyzine
|
Vistrail, anxiolytic
|
|
Anxioytic without sedation or dependance
|
Buspirone, BuSpar
|
|
BN of Chlorpromazine
|
Thorazine (Aliphatic Phenothiazine Typical Antipsychotic)
|
|
Mesoridazine, Thioridazine
|
Piperdine Phenothiazine Typical AP
|
|
Fluphenazine, Perphenazine, Trifluoperazine
|
Piperazine Phenothiazine Typical AP
|
|
Haloperidol, Haldol
|
Typical AP
|
|
Loxapine
|
Typical AP
|
|
Molindone
|
Typical AP
|
|
Thiothixene
|
Typical AP
|
|
Irreversible retinal pigmentation at doses > 800 mg/d
|
Thioridazine, Typical AP
|
|
MOA of typical AP
|
dopamine receptor antagonists
|
|
Difference between typical and atypical AP
|
Atypical AP are more effective for - sx of schizophrenia, significantly less EPS and lower risk for tardive dyskinesia
|
|
MOA of atypical AP
|
Dopa and Serotonin receptor antagonists
|
|
BN of Aripiprazole
|
Abilify, AT AP
|
|
BN of Olanzapine
|
Zyprexa, AT AP
|
|
BN of Quetiapine
|
Seroquel, AT AP
|
|
BN of Risperidone
|
Risperidal, AT AP
|
|
BN of Clozapine
|
Clozaril, AT AP
|
|
BN of Ziprasidone
|
Geodon, AT AP
|
|
SE of Aripiprazole, Abilify
|
N/V, insomnia
|
|
SE of Olanzapine, Zyprexa
|
Monitor blood glucose levels, LFTs, may elevate prolactin levels
|
|
SE of Quetiapine, Seroquel
|
Ortho HypO (initiate dose at 25 mg bid to reduce), lipid abnormalities,
|
|
SE of Clozapine, Clozaril
|
Agranulocytosis, dose related seizure risk, myocarditis
|